Medtronic Expands Minimally Invasive Surgery Line With AF, Valve Products
This article was originally published in The Gray Sheet
Executive Summary
Medtronic is developing a clinical trial for a minimally invasive ablation device for non-concomitant treatment of atrial fibrillation, or lone AF
You may also be interested in...
Canadian Study Prompts Edwards To Rethink PVT Feasibility Trial
Edwards Lifesciences intends to resume a U.S. PVT percutaneous aortic valve feasibility trial by year-end
CoreValve Expands Percutaneous Aortic Valve Trial In Europe
CoreValve plans to begin a 250-patient European pivotal trial of its ReValving self-expanding percutaneous aortic valve replacement system by year-end
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.